Lomitapide Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with lomitapide
K
- Kadcyla (ado-trastuzumab emtansine)
- Kadian (morphine)
- Kaitlib Fe (ethinyl estradiol / norethindrone)
- Kaletra (lopinavir / ritonavir)
- Kalliga (desogestrel / ethinyl estradiol)
- Kalydeco (ivacaftor)
- Kao-Paverin (loperamide)
- Kaopectate 1-D (loperamide)
- Kaopectate II (loperamide)
- Kariva (desogestrel / ethinyl estradiol)
- Katerzia (amlodipine)
- kava
- Kelnor 1 / 35 (ethinyl estradiol / ethynodiol)
- Kelnor 1 / 50 (ethinyl estradiol / ethynodiol)
- Kemeya (drospirenone / ethinyl estradiol)
- Kerendia (finerenone)
- Ketek (telithromycin)
- Ketek Pak (telithromycin)
- ketoconazole
- ketoprofen
- ketorolac
- Kevzara (sarilumab)
- Kimidess (desogestrel / ethinyl estradiol)
- Kiprofen (ketoprofen)
- Kisqali (ribociclib)
- Kisqali Femara Co-Pack (letrozole / ribociclib)
- Klofensaid II (diclofenac topical)
- KneeRelief (acetaminophen / caffeine / magnesium salicylate)
- Kolephrin (acetaminophen / chlorpheniramine / pseudoephedrine)
- Kombiglyze XR (metformin / saxagliptin)
- Korlym (mifepristone)
- Koselugo (selumetinib)
- Krazati (adagrasib)
- Kurvelo (ethinyl estradiol / levonorgestrel)
- Kyleena (levonorgestrel)
- Kynamro (mipomersen)
- Kyprolis (carfilzomib)
- Kyra (drospirenone / ethinyl estradiol)
- Kyzatrex (testosterone)
More about lomitapide
- lomitapide consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antihyperlipidemic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.